MétaCan
Menu
← Back to cohort
Record W3210510291 · doi:10.1101/2021.11.03.21265858

Reappraising Treatment Effect Heterogeneity in Schizophrenia: A Meta-analysis

2021· preprint· en· W3210510291 on OpenAlexafffund
Robert A. McCutcheon, Toby Pillinger, Orestis Efthimiou, Marta M. Maslej, Benoit H. Mulsant, Allan H. Young, Andrea Cipriani, Oliver Howes

Bibliographic record

VenuemedRxiv · 2021
Typepreprint
Languageen
FieldMedicine
TopicSchizophrenia research and treatment
Canadian institutionsUniversity of TorontoCentre for Addiction and Mental Health
FundersNational Institute of Mental HealthMedical Research CouncilKing's College LondonNational Institute for Health and Care ResearchSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungMaudsley CharityWellcome TrustUniversity of TorontoSouth London and Maudsley NHS Foundation TrustH. Lundbeck A/SNational Science Foundation
KeywordsSchizophrenia (object-oriented programming)Meta-analysisQuartilePositive and Negative Syndrome ScalePlaceboAntipsychoticTreatment effectMedicinePsycINFOInternal medicineClinical psychologyPsychologyPsychosisPsychiatryMEDLINEConfidence interval

Abstract

fetched live from OpenAlex

Objective Determining whether individual patients differ in response to treatment (‘treatment effect heterogeneity’) is important as it is a prerequisite to developing personalised treatment approaches. Previous variability meta-analyses of response to antipsychotics in schizophrenia found no evidence for treatment effect heterogeneity. Conversely, individual patient data meta-analyses suggest treatment effect heterogeneity does exist. In the current paper we combine individual patient data with study level data to resolve this apparent contradiction and quantitively characterise antipsychotic treatment effect heterogeneity in schizophrenia. Method Individual patient data (IPD) was obtained from the Yale University Open Data Access (YODA) project. Clinical trials were identified in EMBASE, PsycInfo, and PubMed. Treatment effect heterogeneity was estimated from variability ratios derived from study-level data from 66 RCTs of antipsychotics in schizophrenia (N=17,202). This estimation required a correlation coefficient ( ρ ) between placebo response and treatment effects to be estimated. We estimated this from both study level estimates of the 66 trials, and individual patient data (N=560). Results Both individual patient ( ρ =-0.32, p=0.002) and study level ( ρ =-0.38, p<0.001) analyses yielded a negative correlation between placebo response and treatment effect. Using these estimates we found evidence of clinically significant treatment effect heterogeneity for total symptoms (our most conservative estimate was SD = 13.5 Positive and Negative Syndrome Scale (PANSS) points). Mean treatment effects were 8.6 points which, given the estimated SD, suggests the top quartile of patients experienced beneficial treatment effects of at least 17.7 PANSS points, while the bottom quartile received no benefit as compared to placebo. Conclusions We found evidence of clinically meaningful treatment effect heterogeneity for antipsychotic treatment of schizophrenia. This suggests efforts to personalise treatment have potential for success, and demonstrates that variability meta-analyses of RCTs need to account for relationships between placebo response and treatment effects.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.111
metaresearch head score (Gemma)0.134
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.111
Threshold uncertainty score0.585

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1110.134
Meta-epidemiology (narrow)0.0060.003
Meta-epidemiology (broad)0.0260.088
Bibliometrics0.0180.012
Science and technology studies0.0010.001
Scholarly communication0.0060.004
Open science0.0040.004
Research integrity0.0030.004
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.099
GPT teacher head0.374
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes2
Has abstractyes

Explore more

Same venuemedRxiv→Same topicSchizophrenia research and treatment→French-language works237,207→